Mednet Logo
HomeNephrologyQuestion

How do you approach chronic T cell mediated rejection when patient is intolerant to steroids?

1
3 Answers
Mednet Member
Mednet Member
Nephrology · UCSF

I would really want to know in what way the patient is intolerant to steroids. Depending on the degree of activity, I would also consider thymoglobulin and maximize the mycophenolate. CNI dosing would depend on the degree of chronicity, but in general, I would aim for a tacrolimus level of 6-8 ng/ml...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Nephrology · University of Alabama Birmingham

I would consider anti-thymoglobulin antibody if patient is robust and eGFR is still preserved (>30ml/min) in this instance and optimize immunosuppression as much as tolerated.

A follow up biopsy following treatment may be helpful together with the use of a biomarker to gauge response.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

In the case of chronic active T cell mediated rejection, will maximize oral IS as much as tolerated. Will give thymo in selected cases with limited IFTA and, preserved GFR.

HMW

Register or Sign In to see full answer

How do you approach chronic T cell mediated rejection when patient is intolerant to steroids? | Mednet